kabutan

Delta-Fly Pharma, The Current Fiscal Year's Net Income to Narrow

Thu May 15, 2025 3:35 pm JST Earnings

4598 Delta-Fly Pharma, Inc. 【J-GAAP】

Earnings Report

Delta-Fly Pharma, Inc. <4598> [TSE Growth] announced its financial results after the market closed on May 15th (15:35). The net loss (non-consolidated) for the fiscal year ending March 2025 expanded to a loss of 1.72 billion yen (compared to a loss of 1.42 billion yen in the previous period), but it is expected to shrink to loss of 1.51 billion yen for the fiscal year ending March 2026. This will mark the ninth consecutive term of losses.

In the most recent three-month period, from January to March (4Q), the net loss improved to a deficit of 0.41 billion yen (compared to a loss of 0.45 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 0 -1,315 -1,325 -1,328 -234.5 0 May 15, 2023 J-GAAP
Mar, 2024 0 -1,403 -1,426 -1,429 -198.8 0 May 15, 2024 J-GAAP
Mar, 2025 0 -1,708 -1,718 -1,721 -195.6 0 May 15, 2025 J-GAAP
YoY － -21.7% -20.5% -20.4% +1.6%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance ー -1,817 -1,827 -1,829 -188.0 0 May 15, 2024 J-GAAP
Mar, 2025 Results 0 -1,708 -1,718 -1,721 -195.6 0 May 15, 2025 J-GAAP
Revision Rate － +6.0% +6.0% +5.9% -4.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 0 -916 -915 -917 -111.4 0 Nov 14, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 15, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 0 -1,403 -1,426 -1,429 -198.8 0 May 15, 2024 J-GAAP
Mar, 2025 0 -1,708 -1,718 -1,721 -195.6 0 May 15, 2025 J-GAAP
Mar, 2026 Guidance ー -1,500 -1,510 -1,512 -128.4 0 May 15, 2025 J-GAAP
YoY － +12.2% +12.1% +12.1% +34.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 0 -454 -455 -457 -63.6 -Inf May 15, 2024 J-GAAP
Apr - Jun, 2024 0 -497 -499 -500 -60.8 -Inf Aug 9, 2024 J-GAAP
Jul - Sep, 2024 0 -419 -416 -417 -50.7 -Inf Nov 14, 2024 J-GAAP
Oct - Dec, 2024 0 -377 -390 -390 -45.9 -Inf Feb 14, 2025 J-GAAP
Jan - Mar, 2025 0 -415 -413 -414 -47.1 -Inf May 15, 2025 J-GAAP
YoY － +8.6% +9.2% +9.4% +26.0%

Related Articles